[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Optionystar Bio-Pharmaceuticalystar granted the option innnection with its previously announced public offering of 1,400,000 shares ofmmon stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closingnditions.Net proceeds from the offering are expected to be used for]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Optionystar Bio-Pharmaceuticalystar granted the option innnection with its previously announced public offering of 1,400,000 shares ofmmon stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closingnditions.Net proceeds from the offering are expected to be used for]
[PROSPECTUSYSTAR BIO-PHARMACEUTICALMPANY This is a firmmmitment public offering of 1,400,000 shares of ourmmon stock at a price of $12.98 per share. Ourmmon stock is traded on the NASDAQpital Market under the symbolBI. On June 30, 2009, the last reported market price of ourmmon stock was $17.94 per share. On May 12, 2009, we effected a]
[PROSPECTUSYSTAR BIO-PHARMACEUTICALMPANY This is a firmmmitment public offering of 1,400,000 shares of ourmmon stock at a price of $12.98 per share. Ourmmon stock is traded on the NASDAQpital Market under the symbolBI. On June 30, 2009, the last reported market price of ourmmon stock was $17.94 per share. On May 12, 2009, we effected a]
[Form 10-K /A (Amendment No. 1 ) x For the fiscal year ended: December 31, 2008 o For the transition period from ______________ to _____________ China Pharma Holdings, Inc. Delaware 73-1564807]
[Form 10-K /A (Amendment No. 1 ) x For the fiscal year ended: December 31, 2008 o For the transition period from ______________ to _____________ China Pharma Holdings, Inc. Delaware 73-1564807]
[Form 10-K /A (Amendment No. 1 ) x For the fiscal year ended: December 31, 2008 o For the transition period from ______________ to _____________ China Pharmas, Delaware 73-1564807 (State or other jurisdiction (I.R.S. Employer I.D. No.)orporation or organization) 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216]
[Form 10-K /A (Amendment No. 1 ) x For the fiscal year ended: December 31, 2008 o For the transition period from ______________ to _____________ China Pharmas, Delaware 73-1564807 (State or other jurisdiction (I.R.S. Employer I.D. No.)orporation or organization) 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216]
